NCT03746691View on ClinicalTrials.gov

Effect of Citalopram on Reflux Episodes in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Gastro Esophageal Reflux
Interventions
DRUG

Citalopram HCl

Citalopram HCl IV 20 mg in 100 ml saline will be infused IV over the course of 30 minutes. Volunteers will receive a standard meal, and recordings using high resolution impedance manometry, will be continued for 2 hours.

DRUG

Placebos

Placebo (100 ml saline IV) will be infused IV over the course of 30 minutes. Volunteers will receive a standard meal, and recordings using high resolution impedance manometry, will be continued for 2 hours.

Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03746691 - Effect of Citalopram on Reflux Episodes in Healthy Volunteers | Biotech Hunter | Biotech Hunter